Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Haddock

Showing results (181-190 of 268) with videos related to

Pageof 27
Sort By:
Brachytherapy|May 20, 2018
Technique for the administration of high-dose-rate brachytherapy to the bile duct using a nasobiliary catheterChristopher L Deufel, Keith M Furutani, Robert A Dahl, et al.
American Journal of Clinical Oncology|June 13, 2014
Outcome of Transplant-fallout Patients With Unresectable CholangiocarcinomaTerence T Sio, James A Martenson, Michael G Haddock, et al.
Annals of Surgical Oncology|March 13, 2002
The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancerWilliam E Taylor, John H Donohue, Leonard L Gunderson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2013
Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1Lindsay C Brown, Pamela J Atherton, Michelle A Neben-Wittich, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1997
Locally advanced primary colorectal cancer: IOERT and EBRT +/-5-FUL L Gunderson, H Nelson, J A Martenson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2012
RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canalLisa A Kachnic, Kathryn Winter, Robert J Myerson, et al.
Advances in Radiation Oncology|September 12, 2018
Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomesKrishan R Jethwa, Erik J Tryggestad, Thomas J Whitaker, et al.
JAMA|April 24, 2008
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trialJaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
US intergroup anal carcinoma trial: tumor diameter predicts for colostomyJaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
Practical Radiation Oncology|July 23, 2017
FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgeryAndrea L Arnett, Ann T Packard, Kristin Mara, et al.
Pageof 27

Showing results (181-190 of 268) with videos related to

Sort By:
Pageof 27
Brachytherapy|May 20, 2018
Technique for the administration of high-dose-rate brachytherapy to the bile duct using a nasobiliary catheterChristopher L Deufel, Keith M Furutani, Robert A Dahl, et al.
American Journal of Clinical Oncology|June 13, 2014
Outcome of Transplant-fallout Patients With Unresectable CholangiocarcinomaTerence T Sio, James A Martenson, Michael G Haddock, et al.
Annals of Surgical Oncology|March 13, 2002
The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancerWilliam E Taylor, John H Donohue, Leonard L Gunderson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2013
Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1Lindsay C Brown, Pamela J Atherton, Michelle A Neben-Wittich, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1997
Locally advanced primary colorectal cancer: IOERT and EBRT +/-5-FUL L Gunderson, H Nelson, J A Martenson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 17, 2012
RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canalLisa A Kachnic, Kathryn Winter, Robert J Myerson, et al.
Advances in Radiation Oncology|September 12, 2018
Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomesKrishan R Jethwa, Erik J Tryggestad, Thomas J Whitaker, et al.
JAMA|April 24, 2008
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trialJaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
US intergroup anal carcinoma trial: tumor diameter predicts for colostomyJaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
Practical Radiation Oncology|July 23, 2017
FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgeryAndrea L Arnett, Ann T Packard, Kristin Mara, et al.
Pageof 27